David T. Howton, EVP, General Counsel at Sarepta Therapeutics, Inc. (SRPT), sold 27,804 shares at $105.00 ($2.9M) on 2019-11-22, disclosed to the SEC on 2019-11-26.
Open-market sale of $2.9M SRPT by EVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.00 | 2,957 | $310K | 10.6% |
| 2 | $105.00 | 3,753 | $394K | 13.5% |
| 3 | $105.00 | 18,290 | $1.9M | 65.7% |
| 4 | $107.02 | 2,804 | $300K | 10.3% |
| Total | $105.20 avg | 27,804 | $2.9M | 100% |
| Filing → |
| SLDB | SELL | 2026-02-02 | $486K | — | Filing → |
| SLDB | SELL | 2025-12-04 | $25K | — | Filing → |
| SLDB | SELL | 2025-02-18 | $22K | — | Filing → |